Townsville University Hospital, formerly The Townsville Hospital, is a public tertiary care hospital on Angus Smirth Drive, Douglas, Townsville, Queensland, Australia. It is the largest facility within the Townsville Hospital and Health Service geographic area.

During the past decade, Townsville University Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Townsville University Hospital" #1 sponsor was "AGO Research GmbH" with 1 trials, followed by "BeiGene" with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored, "Ethicon, Inc." with 1 trials sponsored and "Five Prime Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Townsville University Hospital" #1 collaborator was "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Townsville University Hospital" are "Advanced Prostate Carcinoma" (1 trials), "Autosomal Dominant Polycystic Kidney Disease" (1 trials), "Cancer of Prostate" (1 trials), "Castrate Resistant Prostate Cancer" (1 trials) and "Cytopenia" (1 trials). Many other conditions were trialed in "Townsville University Hospital" in a lesser frequency.

Most popular intervention types in "Townsville University Hospital" are "Drug" (8 trials), "Biological" (3 trials), "Radiation" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Carboplatin" (2 trials), "Durvalumab" (2 trials), "Bemarituzumab" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Townsville University Hospital" are 7 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Townsville University Hospital". 1 are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Townsville University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Townsville University Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".